Therapie der Dystonien

  • F. Vassella
Conference paper


Unsere Kenntnisse über die Funktionen der Basalganglien sind immer noch sehr lückenhaft. Im Jahre 1925 prägte Wilson an der Croonian Lecture den berühmt gewordenen Ausspruch: „The basal ganglia situated in the base of the brain retain the characteristics of basements.-viz darkness,“ und im Jahre 1982 gab Marsden [16] seiner Robert Wartenberg Lecture den Titel: „The mysterious motor function of the basal ganglia.“ Das Thema der Therapie der Dystonien kann nicht diskutiert werden, ohne daß die Strukturen und die Funktionen der Basalkerne kurz dargestellt werden.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Angelini L, Rumi V, Nardocci N, Broggi G (1990) Stereotactic surgery: principles, history and techniques. In: Papini M, Pasquinelli A, Gidoni EA (eds) Development, handicap, rehabilitation. Practice and theory. Elsevier. AmsterdamGoogle Scholar
  2. 2.
    Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J (1982) Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 32: 1335PubMedGoogle Scholar
  3. 3.
    Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J (1985) Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35: 73PubMedGoogle Scholar
  4. 4.
    Burke RE, Fahn S, Marsden CD (1986) Torsion dystonia: a double blind, prospective trial of high-dosage trihexyphenidyl. Neurology 36: 160PubMedGoogle Scholar
  5. 5.
    De Jong APJ, Haan EA, Manson JI, Wise GA, Ouvrier RA, Wadman SK (1989) Kinetic study of catecholamine metabolism in hereditary progressive dystonia. Neuropediatrics 20: 3PubMedCrossRefGoogle Scholar
  6. 6.
    Deonna T (1986) DOPA-Sensitive progressive dystonia of childhood with fluctuations of symptoms-Segawa’s syndrome and possible variants. Neuropediatrics 17: 81PubMedCrossRefGoogle Scholar
  7. 7.
    Fahn S (1983) High dosage anticholinergic therapy in dystonia. Neurology 33: 1255PubMedGoogle Scholar
  8. 8.
    Fahn S (1987) Systemic therapy of dystonia. Can J Neurol Sci 14: 528PubMedGoogle Scholar
  9. 9.
    Fahn S (1979) Treatment of dystonia with high-dosage anticholinergic medication. Neurology 29: 605Google Scholar
  10. 10.
    Greene P, Shale H. Fahn S (1988). Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Adv Neurol 50: 547PubMedGoogle Scholar
  11. 11.
    Jankovic J, Orman J (1988) Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 38: 391PubMedGoogle Scholar
  12. 12.
    Jankovic J, Schwartz K (1990) Botulinum toxin injections for cervical dystonia. Neurology 40: 277PubMedGoogle Scholar
  13. 13.
    Jankovic J (1982) Treatment of hyperkinetic movement disorder with tetrabenazine: a double-blind crossover study. Ann Neurol 11: 41PubMedCrossRefGoogle Scholar
  14. 14.
    Lang AE (1988) Dopamine agonists and antagonists in the treatment of idiopathic dystonia. Adv Neuro 50: 561Google Scholar
  15. 15.
    Ludin HP (1988) Das Parkinson-Syndrom. Kohlhammer, StuttgartGoogle Scholar
  16. 16.
    Marsden CD (1982) The mysterious motor function of the basal ganglia: The Robert Wartenberg Lecture. Neurology 32: 514PubMedGoogle Scholar
  17. 17.
    Marsden CD (1986) Basal ganglia and motor dysfunction. In: Asbury AK, McKhann GM, McDonald WJ (eds) Diseases of the nervous system, Vol 394. Saunders, PhiladelphiaGoogle Scholar
  18. 18.
    Marsden CD, Marion MH, Quinn N (1984) The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 47: 1166PubMedCrossRefGoogle Scholar
  19. 19.
    Martin JB, Gusella JF (1988) Huntington’s disease. N Engl J Med 315: 1267Google Scholar
  20. 20.
    Nygaard TG, Marsden CD, Duvoisin RC (1988) Dopa-responsive dystonia. Adv Neurol 50: 377PubMedGoogle Scholar
  21. 21.
    Quinn NP, Lang AE, Sheehy MP, Marsden CD (1985) Lisuride in dystonia. Neurology 35: 766PubMedGoogle Scholar
  22. 22.
    Segawa M, Nomura Y, Tanaka S, Hakamada S, Nagate E, Soda M, Kase M (1988) Hereditary progressive dystonia with marked diurnal fluctuation. — Consideration on its pathophysiology. Adv Neurol 50: 367PubMedGoogle Scholar
  23. 23.
    Seiff SR, Freeman LN, Bluestone DL, Berg BO (1989) Use of botulinum toxin to treat blepharospasm in a 16-year-old with a dystonic syndrome. Pediatr Neurol 5: 121PubMedCrossRefGoogle Scholar
  24. 24.
    Tasker RR, Doorly T, Yamashiro K (1988) Thalamotomy in generalized dystonia. Adv Neurol 50: 615PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • F. Vassella

There are no affiliations available

Personalised recommendations